STAT3 and chronic graft versus host disease: Although our data indicate that targeting STAT3 in donor T cells can prevent acute GVHD while preserving GVL effect, whether targeting STAT3 in donor T cells could control established acute or chronic GVHD without inhibiting GVL activity is not yet known and should be addressed in future studies.